Search One Mission, Inspired by Patients: Defeat Cancer.™ In the past three decades, tremendous progress has been made in the fight against cancer, but there is still so much more work to be done. At Deciphera, we remain steadfast in our mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which we live and work. VIEW OUR PIPELINE 11/30/2021 Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations READ MORE 11/22/2021 Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor READ MORE 11/05/2021 Deciphera Pharmaceuticals Announces Top-Line Results from the INTRIGUE Phase 3 Clinical Study READ MORE Image A targeted approach with extraordinary potential Kinases are enzymes that help regulate cellular function. When they do not work properly, these enzymes contribute to the growth and spread of many cancers. We design switch-control kinase inhibitors with the goal of potentially improving patient responses to treatment and, ultimately, patient outcomes. LEARN MORE ABOUT OUR DISCOVERY PLATFORM Image Inspired by patients, driven by science We come to work every day with a sustained commitment to improving human health - it’s what pushes us to innovate. At Deciphera, we are united in our goal to defeat cancer. SEE WHO WE ARE Image The future of Deciphera We are impacting the lives of people living with cancer by addressing key mechanisms of tumor and drug resistance that limit the results of some existing therapies. We have developed a diverse pipeline of drug candidates with the aim of making a difference in patients’ lives. VIEW OUR PIPELINE Image Discover "The Deciphera Difference" LEARN MORE Image Help us defeat cancer VIEW OPEN POSITIONS twitter linkedin CONTACT US Main navigation Discovery Platform Pipeline Ripretinib Vimseltinib DCC-3116 Preclinical Pipeline Expanded Access Our Medicine QINLOCK® (ripretinib) Who We Are Management Board of Directors Join Us Open Positions Footer Utility Contact Us Terms of Use Privacy Policy Recruiting Privacy Policy Web Accessibility Statement © 2021 Deciphera Pharmaceuticals, Inc. QINLOCK and the QINLOCK logo are registered trademarks of Deciphera Pharmaceuticals, LLC. Deciphera and the Deciphera logo are trademarks of Deciphera Pharmaceuticals, LLC. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Accept All Cookies